Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Oligodendroglioma 1Head and Neck Neoplasms 1Glioblastoma 1Carcinoma, Squamous Cell 1Carcinoma 1Astrocytoma 1

Interventions

Cisplatin 5nimotuzumab 2X-Rays 2Radiotherapy 2Magnetic Resonance Spectroscopy 2trifluridine tipiracil drug combination 1sargramostim 1palladium-bacteriopheophorbide 1padeliporfin 1imgatuzumab 1galactomannan 1futuximab 1fluoromisonidazole 1capmatinib 1cabozantinib 1Tomography, Optical Coherence 1Standard of Care 1Specimen Handling 1Ramucirumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Mitomycin 1LMB-100 1Ipilimumab 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma × DNA × Clear all
NCT02211027 2017-09-07

Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡